P. Joly

A Comparison of Oral and Topical Corticosteroids in Patients with Bullous Pemphigoid

P. Joly, Jean‐Claude Roujeau, Jacques Bénichou et al. · New England Journal of Medicine · 2002 · 617 citations

Medicine, Dermatology, Pharmacotherapy +17

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

P. Joly, Maud Maho‐Vaillant, C. Prost‐Squarcioni et al. · The Lancet · 2017 · 596 citations

Medicine, Internal Medicine, Pharmacotherapy +9

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

Dédée F. Murrell, Sarah Dick, A. R. Ahmed et al. · Journal of the American Academy of Dermatology · 2008 · 589 citations · Full text

Medicine, Immunology, Pathology +13

A Single Cycle of Rituximab for the Treatment of Severe Pemphigus

P. Joly, Hugo Mouquet, Jean‐Claude Roujeau et al. · New England Journal of Medicine · 2007 · 462 citations

Life Sciences, Immunology, Pharmacotherapy +8

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Multiorgan Antiviral T Cell Response

D Picard, Baptiste Janela, V. Descamps et al. · Science Translational Medicine · 2010 · 388 citations

Life Sciences, Immunology, Pathobiology +17